David Miklos, MD, PhD, explains the rationale behind the ZUMA-2 trial of KTE-X19 as well as the efficacy of the drug.
David Miklos
Articles by David Miklos
Latest Updated Articles
KTE-X19 Shows Efficacy as Treatment of MCL in the ZUMA-2 TrialFebruary 21st 2020